The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting

被引:33
作者
Menting, S. P. [1 ]
Van den Reek, J. M. P. A. [2 ]
Baerveldt, E. M. [3 ]
De Jong, E. M. G. J. [2 ]
Prens, E. P. [3 ]
Lecluse, L. L. A. [1 ]
Wolbink, G. J. [4 ]
Van der Kleij, D. [4 ,5 ]
Spuls, Ph. I. [1 ]
Rispens, T. [4 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands
[4] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands
[5] Sanquin Diagnost Serv, Biol Lab, Amsterdam, Netherlands
关键词
RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; IMMUNOGENICITY; ADALIMUMAB;
D O I
10.1111/bjd.13834
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:855 / 857
页数:3
相关论文
共 10 条
[1]   A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interieukin-12/23 monoclonal antibody in subjects with plaque psoriasis [J].
Gottlieb, Alice B. ;
Cooper, Kevin D. ;
McCormick, Thomas S. ;
Toichi, Eiko ;
Everitt, Daniel E. ;
Frederick, Bart ;
Zhu, Yaowei ;
Pendley, Charles E. ;
Graham, Martin A. ;
Mascelli, Mary Ann .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) :1081-1092
[2]   Differential effect of drug interference in immunogenicity assays [J].
Hart, Margreet H. ;
de Vrieze, Henk ;
Wouters, Diana ;
Wolbink, Gerrit-Jan ;
Killestein, Joep ;
de Groot, Els R. ;
Aarden, Lucien A. ;
Rispens, Theo .
JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 372 (1-2) :196-203
[3]   Antidrug antibodies in psoriasis: a systematic review [J].
Hsu, L. ;
Snodgrass, B. T. ;
Armstrong, A. W. .
BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (02) :261-273
[4]   Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study [J].
Kimball, A. B. ;
Papp, K. A. ;
Wasfi, Y. ;
Chan, D. ;
Bissonnette, R. ;
Sofen, H. ;
Yeilding, N. ;
Li, S. ;
Szapary, P. ;
Gordon, K. B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (12) :1535-1545
[5]   Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis One-Year Follow-up [J].
Menting, Stef P. ;
van Lumig, Paula P. M. ;
de Vries, Anna-Christa Q. ;
van den Reek, Juul M. P. A. ;
van der Kleij, Desiree ;
de Jong, Elke M. G. J. ;
Spuls, Phyllis I. ;
Lecluse, Lidian L. A. .
JAMA DERMATOLOGY, 2014, 150 (02) :130-136
[6]   Key findings towards optimising adalimumab treatment: the concentration-effect curve [J].
Pouw, Mieke F. ;
Krieckaert, Charlotte L. ;
Nurmohamed, Michael T. ;
van der Kleij, Desiree ;
Aarden, Lucien ;
Rispens, Theo ;
Wolbink, Gertjan .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) :513-518
[7]   Antibodies to constant domains of therapeutic monoclonal antibodies: Anti-hinge antibodies in immunogenicity testing [J].
Rispens, Theo ;
de Vrieze, Henk ;
de Groot, Els ;
Wouters, Diana ;
Stapel, Steven ;
Wolbink, Gerrit J. ;
Aarden, Lucien A. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2012, 375 (1-2) :93-99
[8]   Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody [J].
Rispens, Theo ;
van Leeuwen, Astrid ;
Vennegoor, Anke ;
Killestein, Joep ;
Aalberse, Rob C. ;
Wolbink, Gerrit J. ;
Aarden, Lucien A. .
ANALYTICAL BIOCHEMISTRY, 2011, 411 (02) :271-276
[9]   A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients [J].
van Schouwenburg, Pauline A. ;
Bartelds, Geertje M. ;
Hart, Margreet H. ;
Aarden, Lucien ;
Wolbink, Gerrit Jan ;
Wouters, Diana .
JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 362 (1-2) :82-88
[10]   Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis [J].
Wolbink, GJ ;
Vis, M ;
Lems, W ;
Voskuyl, AE ;
de Groot, E ;
Nurmohamed, MT ;
Stapel, S ;
Tak, PP ;
Aarden, L ;
Dijkmans, B .
ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :711-715